Market Cap 117.18B
Revenue (ttm) 25.12B
Net Income (ttm) 3.25B
EPS (ttm) N/A
PE Ratio 22.50
Forward PE 20.11
Profit Margin 12.92%
Debt to Equity Ratio 0.64
Volume 1,676,901
Avg Vol 2,526,166
Day's Range N/A - N/A
Shares Out 383.36M
Stochastic %K 59%
Beta 0.78
Analysts Strong Sell
Price Target $388.24

Company Profile

Stryker Corporation operates as a medical technology company in the United States and internationally. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, patient and caregiver safety technologies, navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted v...

Industry: Medical Devices
Sector: Healthcare
Phone: (269) 385-2600
Fax: (269) 385-1062
Address:
1941 Stryker Way, Portage, United States
Thelonius_Stonk
Thelonius_Stonk Jun. 5 at 4:31 PM
$ISRG $SYK green today. lows in
0 · Reply
theoptionsplug
theoptionsplug Jun. 3 at 10:16 PM
$SYK has been in downtrend since March! Is the $290 support area forming a double bottom? - I vote YES!
0 · Reply
BillionerOfKing
BillionerOfKing Jun. 1 at 6:01 PM
$SYK Current Stock Price: $302.56 Contracts to trade: $300.0 SYK Jun 18 2026 Call Entry: $10.30 Exit: $17.16 ROI: 67% Hold ~21 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
BinaryLogic
BinaryLogic May. 30 at 5:52 PM
$MDT Earnings this week upcoming, and I expect the Company to achieve top/bottom lines projected by analysts. Guidance will be critical here (per usual). The Company has shown consistent top-line growth (5YR CAGR 5%), healthy business development across all verticals, good margins (EBITDA: 28.5%, NI: 13%) and strong consistent positive FCF. They have reasonable leverage (Net Debt/EBITDA: 2 and EBIT/Interest Expense: 10) and good liquidity (Current: 2.5, Quick: 1.8). They pay a 3.8% dividend at present valuation. Watch earnings, look for possible fall to $68-69 support line even if data are good. Oversold on 3YR Weekly and 1YR Daily. 25-50% upside from this level (IMO) + Dividend. Growth and Income. The entire sector is Oversold with strong/compelling financials and reasonable valuations. All to consider (IMO) - $ABT $SYK $BSX
1 · Reply
SPY700baby
SPY700baby May. 25 at 4:18 AM
$SYK data breach will cost billions
0 · Reply
OnlyFibs
OnlyFibs May. 24 at 11:11 PM
$SYK Weekly: Most consecutive buy volume ever. A textbook institutional accumulation pattern off the bottom. We’ve reached the inflection point where the fundamentals meet the chart. Trade the levels, not the news. 📉📈 🐂 Bulls to confirm: Break and hold > $328. Next major target $354. 🐻 Bears to confirm: Fail at current resistance, snap below $300 -> Look for a retest of the recent lows. #hovdid $SYK #PriceAction #InstitutionalFlow
0 · Reply
BillionerOfKing
BillionerOfKing May. 21 at 6:52 PM
$SYK Current Stock Price: $315.99 Contracts to trade: $320.0 SYK Jun 18 2026 Call Entry: $8.20 Exit: $12.33 ROI: 50% Hold ~31 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
sideload
sideload May. 21 at 3:47 PM
0 · Reply
moneybag888
moneybag888 May. 20 at 5:17 PM
$SYK $TE 😎
0 · Reply
Highbank
Highbank May. 19 at 2:00 PM
$SYK Continuously
0 · Reply
Latest News on SYK
Stryker announces European launch of Pangea Plating System

2026-05-26T10:10:10.000Z - 13 days ago

Stryker announces European launch of Pangea Plating System


Stryker declares an $0.88 per share quarterly dividend

May 7, 2026, 8:00 AM EDT - 4 weeks ago

Stryker declares an $0.88 per share quarterly dividend


Stryker Transcript: AGM 2026

May 6, 2026, 12:00 PM EDT - 4 weeks ago

Stryker Transcript: AGM 2026


Stryker price target lowered to $330 from $380 at Truist

2026-05-04T13:58:15.000Z - 5 weeks ago

Stryker price target lowered to $330 from $380 at Truist


Stryker price target lowered to $394 from $469 at Barclays

2026-05-04T09:31:48.000Z - 5 weeks ago

Stryker price target lowered to $394 from $469 at Barclays


Stryker price target lowered to $385 from $437 at Baird

2026-05-01T14:34:00.000Z - 5 weeks ago

Stryker price target lowered to $385 from $437 at Baird


Stryker price target lowered to $410 from $465 at Bernstein

2026-05-01T14:08:12.000Z - 5 weeks ago

Stryker price target lowered to $410 from $465 at Bernstein


Stryker price target lowered to $400 from $445 at JPMorgan

2026-05-01T12:53:32.000Z - 5 weeks ago

Stryker price target lowered to $400 from $445 at JPMorgan


Stryker price target lowered to $379 from $397 at BTIG

2026-05-01T12:37:56.000Z - 5 weeks ago

Stryker price target lowered to $379 from $397 at BTIG


Stryker price target lowered to $418 from $454 at Needham

2026-05-01T11:41:05.000Z - 5 weeks ago

Stryker price target lowered to $418 from $454 at Needham


Stryker price target lowered to $400 from $435 at Canaccord

2026-05-01T11:13:19.000Z - 5 weeks ago

Stryker price target lowered to $400 from $435 at Canaccord


Stryker Earnings Call Transcript: Q1 2026

Apr 30, 2026, 4:30 PM EDT - 5 weeks ago

Stryker Earnings Call Transcript: Q1 2026


Stryker Earnings release: Q1 2026

Apr 30, 2026, 4:30 PM EDT - 5 weeks ago

Stryker Earnings release: Q1 2026


Stryker Quarterly report: Q1 2026

Apr 30, 2026, 4:30 PM EDT - 5 weeks ago

Stryker Quarterly report: Q1 2026


Stryker reports Q1 adjusted EPS $2.60, consensus $2.98

2026-04-30T20:26:16.000Z - 5 weeks ago

Stryker reports Q1 adjusted EPS $2.60, consensus $2.98


Stryker reports first quarter 2026 operating results

Apr 30, 2026, 4:05 PM EDT - 5 weeks ago

Stryker reports first quarter 2026 operating results


Stryker price target lowered to $380 from $395 at Truist

2026-04-15T12:50:21.000Z - 7 weeks ago

Stryker price target lowered to $380 from $395 at Truist


Stryker price target lowered to $397 from $412 at BTIG

2026-04-13T11:52:55.000Z - 2 months ago

Stryker price target lowered to $397 from $412 at BTIG


Stryker names Nick Mead Vice President, Investor Relations

Mar 31, 2026, 8:00 AM EDT - 2 months ago

Stryker names Nick Mead Vice President, Investor Relations


Stryker says manufacturing mostly restored after cyberattack

Mar 26, 2026, 12:54 PM EDT - 2 months ago

Stryker says manufacturing mostly restored after cyberattack


Stryker announces Annual Meeting of Shareholders

Mar 23, 2026, 3:00 PM EDT - 2 months ago

Stryker announces Annual Meeting of Shareholders


Stryker Proxy statement: Proxy filing

Mar 23, 2026, 8:00 AM EDT - 2 months ago

Stryker Proxy statement: Proxy filing


Stryker Proxy statement: Proxy filing

Mar 23, 2026, 8:00 AM EDT - 2 months ago

Stryker Proxy statement: Proxy filing


Stryker says cyberattack on its network contained

Mar 17, 2026, 7:40 AM EDT - 2 months ago

Stryker says cyberattack on its network contained


Stryker Says Cyberattack Disruption Is Continuing

Mar 12, 2026, 5:38 PM EDT - 3 months ago

Stryker Says Cyberattack Disruption Is Continuing


Stryker launches SmartHospital Platform

Mar 9, 2026, 9:07 AM EDT - 3 months ago

Stryker launches SmartHospital Platform


Stryker Earnings Call Transcript: Q4 2025

Jan 29, 2026, 4:30 PM EST - 4 months ago

Stryker Earnings Call Transcript: Q4 2025


Stryker Annual report: Q4 2025

Jan 29, 2026, 4:30 PM EST - 4 months ago

Stryker Annual report: Q4 2025


Stryker Earnings release: Q4 2025

Jan 29, 2026, 4:30 PM EST - 4 months ago

Stryker Earnings release: Q4 2025


Stryker reports 2025 operating results and 2026 outlook

Jan 29, 2026, 4:05 PM EST - 4 months ago

Stryker reports 2025 operating results and 2026 outlook


Stryker Transcript: Investor Day 2025

Nov 13, 2025, 2:30 PM EST - 7 months ago

Stryker Transcript: Investor Day 2025


Stryker Slides: FY 2025

Nov 13, 2025, 2:30 PM EST - 7 months ago

Stryker Slides: FY 2025


Stryker raises lower end of annual profit forecast

Oct 30, 2025, 7:04 PM EDT - 7 months ago

Stryker raises lower end of annual profit forecast


Stryker Earnings Call Transcript: Q3 2025

Oct 30, 2025, 4:30 PM EDT - 7 months ago

Stryker Earnings Call Transcript: Q3 2025


Stryker Quarterly report: Q3 2025

Oct 30, 2025, 4:30 PM EDT - 7 months ago

Stryker Quarterly report: Q3 2025


Stryker Earnings release: Q3 2025

Oct 30, 2025, 4:30 PM EDT - 7 months ago

Stryker Earnings release: Q3 2025


Stryker reports third quarter 2025 operating results

Oct 30, 2025, 4:05 PM EDT - 7 months ago

Stryker reports third quarter 2025 operating results


Stryker Launches Incompass Total Ankle System at AOFAS 2025

Sep 9, 2025, 7:20 AM EDT - 9 months ago

Stryker Launches Incompass Total Ankle System at AOFAS 2025


Stryker to host investor day

Aug 15, 2025, 8:00 AM EDT - 10 months ago

Stryker to host investor day


Stryker declares an $0.84 per share quarterly dividend

Aug 7, 2025, 8:00 AM EDT - 10 months ago

Stryker declares an $0.84 per share quarterly dividend


Stryker Earnings Call Transcript: Q2 2025

Jul 31, 2025, 4:30 PM EDT - 11 months ago

Stryker Earnings Call Transcript: Q2 2025


Stryker Quarterly report: Q2 2025

Jul 31, 2025, 4:30 PM EDT - 11 months ago

Stryker Quarterly report: Q2 2025


Stryker Earnings release: Q2 2025

Jul 31, 2025, 4:30 PM EDT - 11 months ago

Stryker Earnings release: Q2 2025


Stryker reports second quarter 2025 operating results

Jul 31, 2025, 4:05 PM EDT - 11 months ago

Stryker reports second quarter 2025 operating results


Thelonius_Stonk
Thelonius_Stonk Jun. 5 at 4:31 PM
$ISRG $SYK green today. lows in
0 · Reply
theoptionsplug
theoptionsplug Jun. 3 at 10:16 PM
$SYK has been in downtrend since March! Is the $290 support area forming a double bottom? - I vote YES!
0 · Reply
BillionerOfKing
BillionerOfKing Jun. 1 at 6:01 PM
$SYK Current Stock Price: $302.56 Contracts to trade: $300.0 SYK Jun 18 2026 Call Entry: $10.30 Exit: $17.16 ROI: 67% Hold ~21 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
BinaryLogic
BinaryLogic May. 30 at 5:52 PM
$MDT Earnings this week upcoming, and I expect the Company to achieve top/bottom lines projected by analysts. Guidance will be critical here (per usual). The Company has shown consistent top-line growth (5YR CAGR 5%), healthy business development across all verticals, good margins (EBITDA: 28.5%, NI: 13%) and strong consistent positive FCF. They have reasonable leverage (Net Debt/EBITDA: 2 and EBIT/Interest Expense: 10) and good liquidity (Current: 2.5, Quick: 1.8). They pay a 3.8% dividend at present valuation. Watch earnings, look for possible fall to $68-69 support line even if data are good. Oversold on 3YR Weekly and 1YR Daily. 25-50% upside from this level (IMO) + Dividend. Growth and Income. The entire sector is Oversold with strong/compelling financials and reasonable valuations. All to consider (IMO) - $ABT $SYK $BSX
1 · Reply
SPY700baby
SPY700baby May. 25 at 4:18 AM
$SYK data breach will cost billions
0 · Reply
OnlyFibs
OnlyFibs May. 24 at 11:11 PM
$SYK Weekly: Most consecutive buy volume ever. A textbook institutional accumulation pattern off the bottom. We’ve reached the inflection point where the fundamentals meet the chart. Trade the levels, not the news. 📉📈 🐂 Bulls to confirm: Break and hold > $328. Next major target $354. 🐻 Bears to confirm: Fail at current resistance, snap below $300 -> Look for a retest of the recent lows. #hovdid $SYK #PriceAction #InstitutionalFlow
0 · Reply
BillionerOfKing
BillionerOfKing May. 21 at 6:52 PM
$SYK Current Stock Price: $315.99 Contracts to trade: $320.0 SYK Jun 18 2026 Call Entry: $8.20 Exit: $12.33 ROI: 50% Hold ~31 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
sideload
sideload May. 21 at 3:47 PM
0 · Reply
moneybag888
moneybag888 May. 20 at 5:17 PM
$SYK $TE 😎
0 · Reply
Highbank
Highbank May. 19 at 2:00 PM
$SYK Continuously
0 · Reply
CapitalMonk
CapitalMonk May. 19 at 1:51 AM
$SYK Price: $313.22 (+2.11%) Trend: Bearish Market Bias (7D): Bullish Bias 📈 Expected Range: ±4.40% RSI: 45.0 | Momentum: Moderate Volume: +10.1% vs avg Volatility: 2.36% Support: $281.00 | Resistance: $339.39 Sourch: http://marketbaubles.com/
0 · Reply
Intuitive_Investing
Intuitive_Investing May. 18 at 8:59 PM
0 · Reply
lextrading
lextrading May. 18 at 2:59 PM
$SYK This is moving along with my other medtech picks!
0 · Reply
SnowTrooper27
SnowTrooper27 May. 16 at 2:23 PM
0 · Reply
SPY700baby
SPY700baby May. 16 at 1:52 PM
$SYK they running out of options to pay the data breach victims which are 100k plus
0 · Reply
SPY700baby
SPY700baby May. 16 at 1:52 PM
$SYK they estimating that hipaa violations alone could be in the $10BILLIONS ..very likely they ll have to sell off wrigth medical brand or the ortho space to survive
0 · Reply
SPY700baby
SPY700baby May. 16 at 1:51 PM
$SYK wait till numbers come out for settlement $4.8 billion
0 · Reply
Intuitive_Investing
Intuitive_Investing May. 15 at 9:17 PM
$SYK $DXCM $ARAY $NUWE - Healthcare stocks are waking up for the summer.
0 · Reply
john565
john565 May. 15 at 2:56 PM
$SYK Easy buy
1 · Reply
Danny696
Danny696 May. 15 at 11:17 AM
$SYK just wanted tilo check in and see how this un ethical company doing.. lol
0 · Reply
cea
cea May. 14 at 7:27 PM
$ABT $HD $MCD $SLS $SYK @Stocktwits Reporting @StockProTrader4 for mass spamming unrelated content to multiple boards. BLOCKED.
0 · Reply
lextrading
lextrading May. 13 at 12:23 AM
$SYK Just summarized its key moat, valuation, and technical points. Looks attractive on a historical basis. This post is open to all. Part 2 will be even better. https://open.substack.com/pub/lextrading/p/the-great-medtech-divergence-ihi?r=2bgp9u&utm_campaign=post&utm_medium=web&showWelcomeOnShare=true
0 · Reply